Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of etoricoxib versus naproxen in ankylosing spondylitis
2010-019872-65Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of etoricoxib in ankylosing spondylitis (AS) (3 arms), sponsored by Merck & Co. Primary endpoints: Objective 1 comparison and Dose comparison endpoint. Started Aug 2010; status: completed.
02
Drugs
etoricoxib
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on 2010-019872-65.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019872-65.